Apr 6, 2017 by Brian FeroldiThis Is Why Radius Health Inc. Tumbled 8.6% in MarchShares swooned after the FDA announced that it needs more time to review the company's pending application.
Apr 5, 2017 by Brian FeroldiHere's Why Rite Aid Stock Swooned 28.2% in MarchShares dropped over renewed concerns that its pending takeover by Walgreens Boots Alliance might not go through.
Apr 4, 2017 by Brian FeroldiAlexion Pharmaceuticals Slid 9.9% in March -- but Why?It was a rough month for the biotech giant. Here's a review of the key headlines that may have influenced its share price.
Apr 4, 2017 by Brian FeroldiWhy Paratek Pharmaceuticals Inc Is Soaring Shares respond positively to the announcement of upbeat data from a phase 3 study.
Apr 4, 2017 by Brian Feroldi3 Hot Stocks to Buy in AprilDexcom, Shopify, and Portola Pharmaceuticals have been on an absolute tear in 2017. Here's why shareholders should expect the trend to continue.
Apr 3, 2017 by Brian Feroldi, Sean Williams, and George Budwell, PhD3 Top Biotech Stocks to Buy in AprilHere's why our team of healthcare contributors thinks TG Therapeutics, Alkermes, and Lexicon Pharmaceuticals are smart biotech bets right now.
Apr 3, 2017 by Brian Feroldi, Dan Caplinger, Rich Duprey, Jason Hall, and Jordan WathenThe 5 Best Dividend Stocks of 2027On the hunt for an income stock that you can hold for at least the next decade? Give these five a closer look.
Apr 3, 2017 by Brian FeroldiHere's Why NovoCure Ltd. Is Skyrocketing TodayShares soar in response to the release of positive clinical updates.
Apr 1, 2017 by Brian Feroldi, Anders Bylund, and Matt DiLallo3 Top Dividend Aristocrats to Buy in AprilAre you on the hunt for an income stock with a long track record of success? Here's why 3M, Medtronic, or TransCanada could be a terrific fit.
Mar 31, 2017 by Brian Feroldi2 Great Stocks You Can Buy on Sale NowWant to buy a high-quality stock trading at a discount? Consider Dollar Tree Stores and AutoZone.
Mar 30, 2017 by Brian FeroldiHere's Why Halozyme Therapeutics, Inc Is FallingShares drop after the company announced that enrollment in a phase 1b/2 trial pancreatic cancer has been halted.
Mar 29, 2017 by Brian Feroldi3 Highest Growth Stocks in the Market TodayLooking for stocks with huge upside potential? These might be worth a closer look.
Mar 29, 2017 by Brian FeroldiHere's Why Vertex Pharmaceuticals Is Flying High TodayThe release of positive data from two important phase 3 trials puts traders in a good mood.
Mar 27, 2017 by Brian FeroldiIn Your 70s? 3 Stocks You Might Want to BuyColgate-Palmolive, Realty Income, and Constellation Brands are all stocks that even conservative investors should warm up to.
Mar 26, 2017 by Brian Feroldi, Dan Caplinger, Rich Duprey, Jason Hall, and Jordan WathenThe 5 Best Dividend Stocks for Beginning InvestorsHere's why our team of contributors thinks these five stocks are ideal choices for novice investors.
Mar 26, 2017 by Brian Feroldi3 Top Biotech Stocks to Buy in 2017Acadia Pharmaceuticals, Regeneron Pharmaceuticals, and Eagle Pharmaceuticals all look like solid choices for the year ahead.
Mar 23, 2017 by Brian FeroldiHere's Why Flexion Therapeutics Inc. Skyrocketed TodayShares shot up 33% on Thursday, fueled by rumors that the company is about to accept a takeover bid.
Mar 23, 2017 by Brian FeroldiIn Your 60s? 2 Stocks You Might Want to BuyHere's why Brookfield Infrastructure Partners and Home Depot could be terrific investment candidates for older investors.
Mar 23, 2017 by Brian Feroldi3 Stocks I'm Never SellingHere's why Mastercard, FactSet Research Systems, and Tesla are on my "hold forever" list.
Mar 22, 2017 by Brian FeroldiDuluth Holdings Inc. Wraps Up 2016 on a High NoteThe niche apparel retailer easily topped its fourth-quarter estimates and issued bullish revenue guidance for 2017.
